EUVIMEDEUVIMED entdecken
Crossref

Drug‐induced liver injury in pediatric age group: Single‐center experience

Burcu Güven iD, Serhat Yıldırım, Zeynep Gökçe Gayretli Aydın, Gökçe Pınar Reis İskenderoğlu, Tülay Kamaşak, Murat Çakır

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 09.06.2025. Verfasst von Burcu Güven und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is no clear information regarding the frequency of drug‐induced liver injury (DILI) in the pediatric age group. In this study, we aimed to investigate the incidence of DILI in pediatric patients and to determine the drug groups responsible for the etiology of DILI and the factors associated with this disease.

Methods

The prospective study was conducted in patients aged 0–18 years and diagnosed with DILI. Age, gender, drugs used by the patients, indications for drug use, duration and dosage of drugs, and laboratory parameters were recorded. Liver injury pattern was classified as hepatocellular, mixed and cholestatic type.

Results

The mean age was 7.8 ± 5.5 years; 187 (62.3%) were male. A total of 90 drugs were found to be responsible for hepatotoxicity, among which methotrexate (8.66%) and cephalosporin group antibiotics (8.66%) were found to be the most commonly identified drugs, followed by carbapenem group antibiotics (6.77%), steroids (6.77%) and mercaptopurine (5.04%). Hepatocellular type developed in 67% ( n = 122), mixed type in 28% ( n = 51) and cholestatic type in 5% ( n = 8) patients.

Conclusions

Hepatocellular type was found to be the most common type among the patterns of liver injury in the pediatric age group. Although antibiotics constitute the leading cause of DILI, antibiotic choices are changing due to increasing resistant infections. The frequency of carbapenem‐induced DILI is increasing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryHumansMaleChildFemaleChild, PreschoolProspective StudiesInfantAdolescentIncidenceInfant, NewbornRisk Factors

Stichwörter der Autor:innen

cholestatic hepatitisdrug‐induced liver injuryhepatocellular hepatitispediatric

Autor:innen und Institutionen

  • Department of Pediatric Gastroenterology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Department of Pediatrics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Department of Pediatric Infectious Diseases, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Department of Pediatric Hematology and Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Department of Pediatric Neurology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.

ORCID-Profile: Burcu Güven

Zitieren

APA

Güven, B., Yıldırım, S., Aydın, Z. G. G., İskenderoğlu, G. P. R., Kamaşak, T., & Çakır, M. (2025). Drug‐induced liver injury in pediatric age group: Single‐center experience. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70099

Vancouver

Güven B, Yıldırım S, Aydın ZGG, İskenderoğlu GPR, Kamaşak T, Çakır M. Drug‐induced liver injury in pediatric age group: Single‐center experience. Pediatrics International. 2025;67(1). doi:10.1111/ped.70099

BibTeX
@article{Gven2025,
  author = {Güven, Burcu and Yıldırım, Serhat and Aydın, Zeynep Gökçe Gayretli and İskenderoğlu, Gökçe Pınar Reis and Kamaşak, Tülay and Çakır, Murat},
  title = {Drug‐induced liver injury in pediatric age group: Single‐center experience},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70099}
}
Kostenlos starten →